These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33216824)

  • 1. Histo-molecular differentiation of renal cancer subtypes by mass spectrometry imaging and rapid proteome profiling of formalin-fixed paraffin-embedded tumor tissue sections.
    Möginger U; Marcussen N; Jensen ON
    Oncotarget; 2020 Nov; 11(44):3998-4015. PubMed ID: 33216824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Mass Spectrometry Is an Accurate Tool in Differentiating Clear Cell Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma: A Proof-of-concept Study.
    Lu HC; Patterson NH; Judd AM; Reyzer ML; Sehn JK
    J Histochem Cytochem; 2020 Jun; 68(6):403-411. PubMed ID: 32466698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities.
    Erlmeier F; Sun N; Shen J; Feuchtinger A; Buck A; Prade VM; Kunzke T; Schraml P; Moch H; Autenrieth M; Weichert W; Hartmann A; Walch A
    Oncology; 2023; 101(2):126-133. PubMed ID: 36198279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Glycan matrix-assisted laser desorption/ionization mass spectrometry imaging protocol for formalin-fixed paraffin-embedded tissues.
    Briggs MT; Ho YY; Kaur G; Oehler MK; Everest-Dass AV; Packer NH; Hoffmann P
    Rapid Commun Mass Spectrom; 2017 May; 31(10):825-841. PubMed ID: 28271569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy.
    Kriegsmann M; Casadonte R; Maurer N; Stoehr C; Erlmeier F; Moch H; Junker K; Zgorzelski C; Weichert W; Schwamborn K; Deininger SO; Gaida M; Mechtersheimer G; Stenzinger A; Schirmacher P; Hartmann A; Kriegsmann J; Kriegsmann K
    J Cancer; 2020; 11(20):6081-6089. PubMed ID: 32922548
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification.
    Le Rhun E; Duhamel M; Wisztorski M; Gimeno JP; Zairi F; Escande F; Reyns N; Kobeissy F; Maurage CA; Salzet M; Fournier I
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):875-890. PubMed ID: 27890679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS.
    Neef SK; Winter S; Hofmann U; Mürdter TE; Schaeffeler E; Horn H; Buck A; Walch A; Hennenlotter J; Ott G; Fend F; Bedke J; Schwab M; Haag M
    Anal Chim Acta; 2020 Oct; 1134():125-135. PubMed ID: 33059858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Proteomic Markers in Head and Neck Cancer Using MALDI-MS Imaging, LC-MS/MS, and Immunohistochemistry.
    Hoffmann F; Umbreit C; Krüger T; Pelzel D; Ernst G; Kniemeyer O; Guntinas-Lichius O; Berndt A; von Eggeling F
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700173. PubMed ID: 30411850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Ng KL; Ellis RJ; Samaratunga H; Morais C; Gobe GC; Wood ST
    Transl Androl Urol; 2019 May; 8(Suppl 2):S123-S137. PubMed ID: 31236330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections.
    Djidja MC; Claude E; Snel MF; Scriven P; Francese S; Carolan V; Clench MR
    J Proteome Res; 2009 Oct; 8(10):4876-84. PubMed ID: 19673544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M; Chinello C; Cazzaniga A; Smith A; Galli M; Piga I; Grasso A; Grasso M; Del Puppo M; Varallo M; Bovo G; Magni F
    J Proteomics; 2019 Jan; 191():38-47. PubMed ID: 29698802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
    Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR
    Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.
    Boskamp T; Lachmund D; Oetjen J; Cordero Hernandez Y; Trede D; Maass P; Casadonte R; Kriegsmann J; Warth A; Dienemann H; Weichert W; Kriegsmann M
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):916-926. PubMed ID: 27836618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of chromophobe renal cell carcinoma and benign renal oncocytoma biopsies reveals shared metabolic dysregulation.
    Carvalho LB; Jorge S; López-Fernández H; Lodeiro C; Dhir R; Campos Pinheiro L; Medeiros M; Santos HM; Capelo JL
    Clin Proteomics; 2023 Nov; 20(1):54. PubMed ID: 38017382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
    Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
    Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples.
    Buck A; Ly A; Balluff B; Sun N; Gorzolka K; Feuchtinger A; Janssen KP; Kuppen PJ; van de Velde CJ; Weirich G; Erlmeier F; Langer R; Aubele M; Zitzelsberger H; Aichler M; Walch A
    J Pathol; 2015 Sep; 237(1):123-32. PubMed ID: 25965788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry?
    Buck A; Balluff B; Voss A; Langer R; Zitzelsberger H; Aichler M; Walch A
    Anal Chem; 2016 May; 88(10):5281-9. PubMed ID: 27065343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Ucal Y; Tokat F; Duren M; Ince U; Ozpinar A
    Thyroid; 2019 Aug; 29(8):1125-1137. PubMed ID: 31064269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.